0.91% -0.0072

Handel nachbörslich: .77

AEON Biopharma Inc. (AEON)

Überblick Nachrichten Preisverlauf Forum Prognose

AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten

AEON Biopharma Inc. (AEON)

AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten

AEON Q4 2025 Earnings: Deep EPS Miss Amid Pre-Revenue StageEarnings Per Share - Newser

AEON Biopharma Q4 2025 Earnings: Major EPS Miss and No Revenue Weigh on Investor SentimentEarnings Expansion Phase - Newser

AEON Biopharma Inc. (AEON) Q4 2025 Earnings: Significant EPS Miss and Stock Decline Amid Development ChallengesHigh Growth Earnings - Newser

AEON Biopharma Dips 2.74% as Stock Nears Critical Support at $0.76Watchlist Stock Ideas - Newser

12 Health Care Stocks Moving In Monday's Intraday Session - Sahm

AEON Stock Price, Quote & Chart | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill

AEON SEC FilingsAeon Biopharma 10-K, 10-Q, 8-K Forms - Stock Titan

AEON Biopharma shares fall over 2% on quarterly loss - Investing.com

AEON Biopharma shares fall over 2% on quarterly loss By Investing.com - Investing.com South Africa

AEON Biopharma Reports Q1 Financial Results - Intellectia AI

AEON Biopharma Releases Updated Investor Relations Presentation - TipRanks

AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

AEON Biopharma (AEON) releases May 2026 corporate investor presentation via Form 8-K - Stock Titan

AEON Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

AEON Biopharma (NYSE: AEON) Q1 2026 loss, financing deals and going concern risk - Stock Titan

AEON Biopharma (NYSE: AEON) Q1 2026 loss, FDA boosts ABP-450 plan and debt cut - Stock Titan

AEON’s Botox biosimilar plan gets FDA feedback as debt falls 90% - Stock Titan

TradingKey - TradingKey

AEON Technical Analysis | Trend, Signals & Chart Patterns | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill

AEON Biopharma (AEON) details 2026 meeting, director elections and KPMG ratification - Stock Titan

AEON Biopharma Sets Annual Shareholder Meeting - The Manila Times

AEON cites going concern audit note, cash into Q3 2026 - Stock Titan

AEON Biopharma receives additional NYSE American non-compliance notice - MSN

AEON Bio (AEON) Stock: Why Brand Strength (Eye on Rally) 2026-04-20Market Movers - Cổng thông tin điện tử tỉnh Tây Ninh

Migraine Market: Pharma Pipeline Fuels Rapid Expansion by 2034 – DelveInsight | Eli Lilly and Company, Axsome Therapeutics, AEON Biopharma, Charleston Laboratories, Amgen, Teva Pharma, Anne Lindblad - Barchart.com

AEON (AEON Biopharma) PB Ratio : (As of Apr. 10, 2026) - GuruFocus

Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN

Weekly Earnings: Will AEON Biopharma Inc be affected by tariffs2026 Big Picture & High Conviction Investment Ideas - baoquankhu1.vn

What is the bull case for AEON Bio (AEON) Stock | AEON Q4 2025 Earnings: AEON Biopharma Inc. misses EPS, no revenue postedPre-Earnings Drift - Newser

Is AEON Bio (AEON) Stock Rebounding | Price at $0.90, Up 1.27%Professional Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai

AEON Biopharma Receives NYSE American Non-Compliance Notice Due to Stockholders’ Equity Deficit and Ongoing Listing Challenges - Minichart

AEON Biopharma Receives Additional NYSE American Noncompliance Notice - The Globe and Mail

AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards - The Manila Times

AEON Biopharma, Inc. (AEON) stock price, news, quote and history - Yahoo Finance Singapore

AEON Biopharma Receives Second NYSE American Notice for Listing Non-Compliance - geneonline.com

AEON (AEON) CFO awarded 754,717 restricted stock units vesting over four years - Stock Titan

AEON Biopharma (AEON) CFO John Bencich files initial insider ownership report - Stock Titan

AEON Biopharma Faces Listing Compliance Risk - Intellectia AI

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times

AEON Biopharma Received Notice of Noncompliance - TradingView — Track All Markets

New AEON finance chief gets stock awards tied to NYSE compliance - Stock Titan

Form 8-KCurrent report - ADVFN

AEON stays on NYSE despite $55 million deficit as deadline nears - Stock Titan

AEON Q4 2025 Earnings: AEON Biopharma Inc. Posts Big EPS Miss, No Revenue - Newser

AEON Forecast, Price Target & Analyst Ratings | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill

AEON Biopharma 2025 Financial Review - AlphaStreet

Stock Market Recap: Whats the profit margin of AEON Biopharma Inc - baoquankhu1.vn

AEON Biopharma reports biosimilar progress, secures financing By Investing.com - Investing.com Australia

AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program - The Manila Times

Can AEON Biopharma Inc keep up with sector leaders2026 Price Swings & AI Powered Market Entry Strategies - baoquankhu1.vn

Ähnlich wie AEON